Verlinsky Yury, Strelchenko Nick, Shkumatov Artem, Kukharenko Valeri, Verlinsky Oleg, Kuliev Anver
Reproductive Genetics Institute, 2825 N Halsted St, Chicago, IL 60657, USA.
Stem Cell Rev. 2006;2(4):297-9. doi: 10.1007/BF02698056.
Recent progress in somatic cell nuclear transfer (SCNT) provides the evidence for the presence of reprogramming factors in human embryonic stem cells (hESC). Hybrid hESC with donor human somatic nuclei have been established, but the resulting hybrid hESC contained DNA originating from both hESC and donor somatic cells. There is still no method to completely replace the hESC nuclei by the nuclei of somatic cells and to obtain the pure colonies of hESC with donor genotype. We present here the original technology, which is based on enucleation of h ESC and their fusion with the adult somatic cells, resulting in the establishment of individual-specific hESC with the genotype of the donor somatic cells. The resulting constructs was demonstrated to have the "stemness" of hESC and the genotype of the donor somatic cells. So this "Stembrid technology," may be used for the construction of patient-specific hESC.
体细胞核移植(SCNT)的最新进展为人类胚胎干细胞(hESC)中重编程因子的存在提供了证据。已建立了带有供体人类体细胞核的杂交hESC,但所得的杂交hESC包含源自hESC和供体体细胞的DNA。目前仍没有方法用体细胞的细胞核完全替代hESC的细胞核,从而获得具有供体基因型的hESC纯克隆。我们在此展示了一项原创技术,该技术基于对hESC进行去核并使其与成人体细胞融合,从而建立具有供体体细胞基因型的个体特异性hESC。结果表明,所得构建体具有hESC的“干性”以及供体体细胞的基因型。因此,这种“干细胞桥技术”可用于构建患者特异性hESC。